Please login to the form below

Not currently logged in
Email:
Password:

Hemophilia

This page shows the latest Hemophilia news and features for those working in and with pharma, biotech and healthcare.

Roche highlights Hemlibra data as key FDA date approaches

Roche highlights Hemlibra data as key FDA date approaches

Expanded use would see revenues take off

Latest news

  • Pfizer enters late-stage haemophilia B gene therapy trial Pfizer enters late-stage haemophilia B gene therapy trial

    begin our Phase 3 programme evaluating fidanacogene elaparvovec for the treatment of hemophilia B. ... We look forward to the opportunity to continue the progress achieved by Spark Therapeutics for patients living with hemophilia B.”.

  • More encouraging data for Spark and Pfizer’s potential haemophilia B cure More encouraging data for Spark and Pfizer’s potential haemophilia B cure

    These data are presented today by Spencer K. Sullivan, M.D., haematologist and clinical investigator,  Mississippi Center for Advanced Medicine, at the World Federation of Hemophilia (WFH) World Congress in Glasgow,

  • Shire to customise MicroHealth's app for haemphilia patients Shire to customise MicroHealth's app for haemphilia patients

    MicroHealth, a digital health company co-created by a hemophilia patient, originally launched its app in 2011 to help improve haemophilia patient care and outcomes. ... I wanted to develop a tool that would help streamline hemophilia care to produce

  • Novo launches haemophilia tracking app Novo launches haemophilia tracking app

    The other unusual feature is the way it syncs with Novo's haemophilia inhibitor website Changing Possibilities in Hemophilia, where members can access a range of reporting features, such as treatment

  • R&D news in brief

    In one trial, the safety results, presented at the World Federation of Hemophilia conference, found that BAY 79-4980 showed no significant differences compared to Kogenate FS.

More from news
Approximately 2 fully matching, plus 4 partially matching documents found.

Latest appointments

  • uniQure appoints chief executive officer uniQure appoints chief executive officer

    As we head into 2017, we are fully focused on achieving several important catalysts, including rapidly progressing our hemophilia B programme into late-stage development and advancing our gene therapy candidates

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Living with haemophilia – the power of knowledge

    In honour of World Hemophilia Day, we are considering the importance of sharing knowledge. ... Haemophilia 2013; 19 (4): 487–498. 8. WFH guidelines for the management of hemophilia.

  • Porterhouse Medical Group

    On World Hemophilia Day, Porterhouse Medical explores changing attitudes towards exercising with the disease and share guides that help people with haemophilia stay active.

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics